Search results


Found 1771 results. Displaying page 40 of 119

  1. 5 July 2022

    Exemption Notice - Financial Markets Conduct Goodman Group

    The Financial Markets Conduct (Goodman Group) Exemption Notice 2022 provides relief for a five year period in relation to the offer of stapled securities to employees in New Zealand under an employee incentive scheme.
  2. 5 July 2022

    FMA DIMS SC2 consultation feedback form

    Feedback form for consultation paper: Proposed variation to Standard Condition 2 of Standard Conditions for DIMS licences – Incidental financial advice
  3. 5 July 2022

    FMA DIMS SC2 consultation paper

    Consultation paper: Proposed variation to Standard Condition 2 of Standard Conditions for DIMS licences – Incidental financial advice
  4. 28 June 2022

    NZX Obligations Review 2022

    Findings from the FMA's review of how well NZX is meeting its licensed market operator obligations, for the period 1 January to 31 December 2021.
  5. 23 June 2022

    Cyber Security and Operational Systems Resilience

    This information sheet assists market services licensees (excluding benchmark administrators) licensed under Part 6 of the Financial Markets Conduct Act 2013 (FMC Act) to enhance the resilience of their cyber and operational systems. While this information sheet is designed to apply to a broad range of sectors, entities with complex cyber security and operational systems should consider the specific technology requirements and obligations that apply to their sector.
  6. 16 June 2022

    Investor Confidence Report 2022

    The Investor confidence Research report 2022 measures attitudes towards and investment in New Zealand’s financial markets.
  7. 14 June 2022

    Cigna and OnePath Life - Enforceable Undertaking

    OnePath Life (NZ) Limited and Cigna Life Insurance New Zealand Limited will jointly pay $180,000 to the FMA after admitting liability for breaching the fair dealing provisions of the Financial Markets Conduct Act 2013 (FMCA). 14 June 2022
  8. 1 June 2022

    Exemption Notice - Haleon plc

    The Financial Markets Conduct (Haleon plc) Exemption Notice 2022 exempts GlaxoSmithKline plc (GSK) and Haleon plc (Haleon) from the obligations in Part 3 (Disclosure of offers of financial products) of the Financial Markets Conduct Act 2013.